Strides Pharma Science Limited (NSE: STAR)
India flag India · Delayed Price · Currency is INR
1,359.75
+14.90 (1.11%)
Sep 6, 2024, 3:29 PM IST

Strides Pharma Science Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Jun '24 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2019 - 2015
Net Income
--706.14-2,026-4,6022,684363.91
Upgrade
Depreciation & Amortization
-2,2072,3012,1621,8881,736
Upgrade
Other Amortization
--131.21168.49174.59142.07
Upgrade
Loss (Gain) From Sale of Assets
--14.32-41.0741.9-23.3853.05
Upgrade
Asset Writedown & Restructuring Costs
-1,575330.41,774-194.45
Upgrade
Loss (Gain) From Sale of Investments
---812.95-558.62-241.01-
Upgrade
Loss (Gain) on Equity Investments
-1,7572,8531,108978.191,077
Upgrade
Stock-Based Compensation
-15.8613.01-7.0968.0217.53
Upgrade
Provision & Write-off of Bad Debts
-175.67344.171.7894.61114.74
Upgrade
Other Operating Activities
-2,7881,930-767.152,4711,795
Upgrade
Change in Accounts Receivable
-390.9-3,474-587.95-1,248-1,591
Upgrade
Change in Inventory
-307.04-81.38281.86-4,140-1,625
Upgrade
Change in Accounts Payable
--1,485-1,023-1,5932,108-45.99
Upgrade
Operating Cash Flow
-7,011444.11-2,5784,8142,048
Upgrade
Operating Cash Flow Growth
-1478.58%--135.09%241.00%
Upgrade
Capital Expenditures
--1,182-949.38-1,434-2,975-1,500
Upgrade
Sale of Property, Plant & Equipment
-888.0672.58753.7439.5836.75
Upgrade
Cash Acquisitions
--58.78--2,195-78.86-272.26
Upgrade
Divestitures
-66.695,193---
Upgrade
Investment in Securities
--765.96-1,5611,569-2,4491,564
Upgrade
Other Investing Activities
-90.69269.64118.67254.6313,194
Upgrade
Investing Cash Flow
--1,5033,025-1,187-5,20813,062
Upgrade
Short-Term Debt Issued
-2,424-4,564--
Upgrade
Long-Term Debt Issued
-1,0733,3044,5075,675686.12
Upgrade
Total Debt Issued
-3,4983,3049,0715,675686.12
Upgrade
Short-Term Debt Repaid
---504.55--1,824-442.07
Upgrade
Long-Term Debt Repaid
--7,901-3,081-3,132-2,472-14,087
Upgrade
Total Debt Repaid
--7,901-3,586-3,132-4,296-14,529
Upgrade
Net Debt Issued (Repaid)
--4,403-281.825,9391,378-13,843
Upgrade
Issuance of Common Stock
-526.7413.6736.1834.994.8
Upgrade
Common Dividends Paid
--135.17--224.31-179.15-307.79
Upgrade
Other Financing Activities
--2,922-1,871-1,538-1,392-1,717
Upgrade
Financing Cash Flow
--6,933-2,1394,213-157.96-17,094
Upgrade
Foreign Exchange Rate Adjustments
-1.621.461.28-12.2148.48
Upgrade
Miscellaneous Cash Flow Adjustments
--1.35-3.39---
Upgrade
Net Cash Flow
--1,4251,328448.96-564-1,837
Upgrade
Free Cash Flow
-5,829-505.27-4,0121,840547.85
Upgrade
Free Cash Flow Growth
----235.77%-
Upgrade
Free Cash Flow Margin
-14.39%-1.37%-13.07%5.55%1.99%
Upgrade
Free Cash Flow Per Share
-64.06-5.61-44.7020.516.12
Upgrade
Cash Interest Paid
-2,9222,2421,5381,3941,708
Upgrade
Cash Income Tax Paid
--242.47-876.45-23.28-1,568449.78
Upgrade
Levered Free Cash Flow
-2,4622,939-8,600-971.53,759
Upgrade
Unlevered Free Cash Flow
-4,4274,299-7,689-1944,601
Upgrade
Change in Net Working Capital
--120.15-1,9037,0952,026-1,870
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.